Skip to Main Content

Author Details

Jonathan Beesley
QIMR Berghofer Medical Research Institute
1985
147
52
PMIDPaper TitleJournal TitlePublished Year
37144467Redefining normal breast cell populations using long noncoding RNAs.Nucleic Acids Res2023
37144467Redefining normal breast cell populations using long noncoding RNAs.Nucleic Acids Res2023
36991492CRISPR screens identify gene targets at breast cancer risk loci.Genome Biol2023
36991492CRISPR screens identify gene targets at breast cancer risk loci.Genome Biol2023
35501337Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.NPJ Breast Cancer2022
35501337Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.NPJ Breast Cancer2022
34355204Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals.HGG Adv2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
33529165RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.J Clin Invest2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34355204Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals.HGG Adv2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
34611289Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.Sci Rep2021
33529165RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.J Clin Invest2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
34611289Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.Sci Rep2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
32871102eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.Am J Hum Genet2020
31910864Non-coding RNAs underlie genetic predisposition to breast cancer.Genome Biol2020
31910858Chromatin interactome mapping at 139 independent breast cancer risk signals.Genome Biol2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
32714364SNPs in lncRNA Regions and Breast Cancer Risk.Front Genet2020
32871102eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.Am J Hum Genet2020
32622267Immune Cell Associations with Cancer Risk.iScience2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
31910864Non-coding RNAs underlie genetic predisposition to breast cancer.Genome Biol2020
31910858Chromatin interactome mapping at 139 independent breast cancer risk signals.Genome Biol2020
32714364SNPs in lncRNA Regions and Breast Cancer Risk.Front Genet2020
32622267Immune Cell Associations with Cancer Risk.iScience2020
31090900Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.Ann Oncol2019
31090900Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.Ann Oncol2019
29344954Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
30054594Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma.Nat Genet2018
30429480Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.Nat Commun2018
29958288The importance of using public data to validate reported associations.PLoS Genet2018
29344954Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.J Pathol2018
29367611Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.Sci Rep2018
29633761Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Nat Commun2018
30054594Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma.Nat Genet2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
29958288The importance of using public data to validate reported associations.PLoS Genet2018
30429480Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.Nat Commun2018
29633761Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Nat Commun2018
29367611Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.Sci Rep2018
27171545Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.Genet Med2017
28604730Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.Nat Genet2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
28978027Functional dissection of breast cancer risk-associated <i>TERT</i> promoter variants.Oncotarget2017
  • 1 - 50 of 294

Recommended Authors

Jingxiong Xu
Lunenfeld-Tanenbaum Research Institute
Career Start Year 2014
Number of shared co-authors 6
Aurelie Vogt
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 28
Florentine S Hilbers
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 24
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Maria P Intermaggio
University of New South Wales
Career Start Year 2010
Number of shared co-authors 91
Jianxin Shi
National Cancer Institute, 9609 Medical Center Drive
Career Start Year 2007
Number of shared co-authors 84
Alicia Y Zhou
University of California san francisco
Career Start Year 2007
Number of shared co-authors 5
Swneke D Bailey
Research Institute of the McGill University Health Centre
Career Start Year 2006
Number of shared co-authors 10
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2006
Number of shared co-authors 47
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 43
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 37
J??r??mie Nsengimana
Population Health Sciences Institute, Newcastle University
Career Start Year 2004
Number of shared co-authors 10
Melissa Rotunno
Boston Children's Hospital and Harvard Medical School
Career Start Year 2004
Number of shared co-authors 36
Abul Kalam Azad
University of Dhaka
Career Start Year 2004
Number of shared co-authors 5
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 2
Sandya Liyanarachchi
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year 2002
Number of shared co-authors 11
Howard H Yang
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 10
Joshua Millstein
Keck School of Medicine, University of Southern California
Career Start Year 2001
Number of shared co-authors 79
Andrew D Skol
The University of Chicago
Career Start Year 2001
Number of shared co-authors 20
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 18
Sevtap Savas
Memorial University
Career Start Year 1999
Number of shared co-authors 7
Giovanni Parmigiani
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 21
Laurent Briollais
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Career Start Year 1996
Number of shared co-authors 17
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 31
Unnur Thorsteinsdottir
University of Iceland
Career Start Year 1995
Number of shared co-authors 78
Meredith Yeager
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 92
Thomas J Hudson
Ontario Institute for Cancer Research
Career Start Year 1991
Number of shared co-authors 87
Ming K Lee
University of Washington
Career Start Year 1988
Number of shared co-authors 15
Daniela Seminara
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 104
Elizabeth M Gillanders
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 84

Collaborators

Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 129
Douglas F Easton
University of Cambridge
Co-authored papers 86
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 80
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Co-authored papers 72
Fergus J Couch
Mayo Clinic
Co-authored papers 70
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 66
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 59
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 56
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 56
Hoda Anton-Culver
University of California irvine
Co-authored papers 55
Graham G Giles
Co-authored papers 53
Irene L Andrulis
University of Toronto
Co-authored papers 51
Diether Lambrechts
Co-authored papers 51
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 50
Jan Lubinski
Pomeranian Medical University
Co-authored papers 50
Alison M Dunning
Co-authored papers 50
Per Hall
Co-authored papers 46
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 45
Roger L Milne
Co-authored papers 45
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 43
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 43
Anna H Wu
University of Southern California
Co-authored papers 42
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 39
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 36
Janet E Olson
Mayo Clinic
Co-authored papers 35
Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 35
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 34
Andrew Berchuck
Duke School of Medicine
Co-authored papers 33
Christopher A Haiman
University of Southern California
Co-authored papers 32
Børge G Nordestgaard
Co-authored papers 32
Release 1.2